Thompson Davis & Co., Inc. recently announced the acquisition of new stake in Allied Healthcare Products Inc. (NASDAQ:AHPI). The institutional investor has increased its shareholding in the Healthcare company by 30.00% to 13000.0 shares with purchase of 3000.0 shares. This fresh investment now brings its stake to 0.32% valued currently at $11960.0. In addition, Tower Research Capital LLC raised its holdings by 2362.0 to 2362.0 shares.
With over 0.58 million Allied Healthcare Products Inc. (AHPI) shares trading Tuesday and a closing price of $1.18 on the day, the dollar volume was approximately $0.68 million. The shares have shown a negative half year performance of -38.22% and its price on 01/24/23 gained nearly 10.28%. Currently, there are 4.01M common shares owned by the public and among those 3.44M shares have been available to trade.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for AHPI have a consensus price objective of $18.00. The analysts have set the share’s price value over the next 12 months at a high of $18.00 and a low of $18.00. But an upside of 93.44% will see the stock hit the forecast high price target while median target price for the stock is $18.00.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Allied Healthcare Products Inc. are Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and DFA US Small Cap Portfolio. Vanguard Extended Market Index Fu owns 28946.0 shares of the company’s stock, all valued at over $26630.0. The company sold 16642.0 shares recently to bring their total holdings to about 0.72% of the shares outstanding. DFA US Small Cap Portfolio now owns shares totaling to 0.38% of the shares outstanding.
Shares of Allied Healthcare Products Inc. (NASDAQ: AHPI) opened at $1.12, up $0.05 from a prior closing price of $1.07. However, the script later moved the day high at 1.3600, up 10.28%. The company’s stock has a 5-day price change of 7.28% and -3.28% over the past three months. AHPI shares are trading 28.23% year to date (YTD), with the 12-month market performance down to -67.76% lower. It has a 12-month low price of $0.80 and touched a high of $3.71 over the same period. AHPI has an average intraday trading volume of 36.20K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 16.41%, 9.37%, and -30.08% respectively.
Institutional ownership of Allied Healthcare Products Inc. (NASDAQ: AHPI) shares accounts for 4.10% of the company’s 4.01M shares outstanding. Mutual fund holders own 10.62%, while other institutional holders and individual stakeholders account for 2.52% and 1.63% respectively.
It has a market capitalization of $4.59M and a beta (3y monthly) value of -2.46. The earnings-per-share (ttm) stands at -$1.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.55% over the week and 11.44% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0.
Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
